National Cancer Institute at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

National Cancer Institute brings 1 presentation to AMP 2026 in Seattle. Its program centres on best practice guidance for artificial intelligence and machine learning in molecular diagnostics. The agency funds and conducts cancer research as part of the National Institutes of Health.

OrganizationAMP 2026 Attendance
cancer.gov
Gov/NGO
US federal agency funding and conducting cancer research, part of the National Institutes of Health.
Talk
Sat, Nov 14
1:15pm–1:45pm
Part of AMP Clinical Practice Committee Work in Progress Updates - Informatics
AMP Best Practice Guidance for Artificial Intelligence (AI) and Machine Learning (ML) for Molecular Diagnostics Part 1 Working Group
Best practices for validating and deploying AI models in clinical molecular workflows, and how they differ from older machine learning.

Explore the full AMP 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Seattle. Leave your work email and we’ll be in touch.

Privacy

Download the full AMP 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from National Cancer Institute

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction